| dc.contributor |
Massachusetts Institute of Technology. Department of Biology |
|
| dc.creator |
Chew, Marvin |
|
| dc.creator |
Ye, Weijian |
|
| dc.creator |
Omelianczyk, Radoslaw Igor |
|
| dc.creator |
Pasaje, Charisse Flerida |
|
| dc.creator |
Hoo, Regina |
|
| dc.creator |
Chen, Qingfeng |
|
| dc.creator |
Niles, Jacquin C |
|
| dc.creator |
Chen, Jianzhu |
|
| dc.creator |
Preiser, Peter |
|
| dc.date |
2022-12-07T16:11:56Z |
|
| dc.date |
2022-12-07T16:11:56Z |
|
| dc.date |
2022 |
|
| dc.date |
2022-12-07T16:09:15Z |
|
| dc.date.accessioned |
2023-02-17T20:08:56Z |
|
| dc.date.available |
2023-02-17T20:08:56Z |
|
| dc.identifier |
https://hdl.handle.net/1721.1/146779 |
|
| dc.identifier |
Chew, Marvin, Ye, Weijian, Omelianczyk, Radoslaw Igor, Pasaje, Charisse Flerida, Hoo, Regina et al. 2022. "Selective expression of variant surface antigens enables Plasmodium falciparum to evade immune clearance in vivo." Nature Communications, 13 (1). |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/242129 |
|
| dc.description |
<jats:title>Abstract</jats:title><jats:p><jats:italic>Plasmodium falciparum</jats:italic> has developed extensive mechanisms to evade host immune clearance. Currently, most of our understanding is based on in vitro studies of individual parasite variant surface antigens and how this relates to the processes in vivo is not well-understood. Here, we have used a humanized mouse model to identify parasite factors important for in vivo growth. We show that upregulation of the specific PfEMP1, VAR2CSA, provides the parasite with protection from macrophage phagocytosis and clearance in the humanized mice. Furthermore, parasites adapted to thrive in the humanized mice show reduced NK cell-mediated killing through interaction with the immune inhibitory receptor, LILRB1. Taken together, these findings reveal new insights into the molecular and cellular mechanisms that the parasite utilizes to coordinate immune escape in vivo. Identification and targeting of these specific parasite variant surface antigens crucial for immune evasion provides a unique approach for therapy.</jats:p> |
|
| dc.format |
application/pdf |
|
| dc.language |
en |
|
| dc.publisher |
Springer Science and Business Media LLC |
|
| dc.relation |
10.1038/S41467-022-31741-2 |
|
| dc.relation |
Nature Communications |
|
| dc.rights |
Creative Commons Attribution 4.0 International license |
|
| dc.rights |
https://creativecommons.org/licenses/by/4.0/ |
|
| dc.source |
Nature |
|
| dc.title |
Selective expression of variant surface antigens enables Plasmodium falciparum to evade immune clearance in vivo |
|
| dc.type |
Article |
|
| dc.type |
http://purl.org/eprint/type/JournalArticle |
|